binding site of Escherichia coli (E. coli) pyruvate dehydrogenase multienzyme complex E1 (PDHc E1), a series of novel ‘open-chain’ classes of ThDP analogs A, B, and C with N-acylhydrazone moieties was designed and synthesized to explore their activities against E. coli PHDc E1 in vitro and their inhibitory activity against microbial diseases were further evaluated in vivo. As a result, A1–23 exhibited moderate
通过靶向
硫胺二
磷酸(THDP)结合位点的大肠杆菌(大肠杆菌)
丙酮酸脱氢酶多酶复合物E1(PDHC E1),一系列的THDP小说“开链”类的类似物甲,乙,和Ç与ñ -设计并合成了酰基to部分,以探讨它们在体外对大肠杆菌PHDc E1的活性,并在体内进一步评价其对微
生物疾病的抑制作用。结果,A1 – 23对大肠杆菌PDHc E1表现出了中度到强效的抑制活性(IC 50 = 0.15–23.55μM)。有效的
抑制剂A13,
A14,A15,C2具有很强的抑制活性,对大肠杆菌PDHc E1的IC 50值为0.60、0.15、0.39和0.34μM,并且在微
生物和哺乳动物之间具有良好的酶选择性抑制作用。特别是,最有效的
抑制剂A14可以控制99.37%的米地黄单胞菌(Xanthimonas oryzae pv)。Oryzae。此外,化合物
A14在大肠杆菌中的结合特征对PDHc E1进行了研究,以通过分子